- This event has passed.
On December 8, the American Antitrust Institute will host its third annual Invitational Symposium on the Future of Private Antitrust Enforcement at the National Press Club in Washington D.C.
This year, our program will cover some of the most current and relevant issues in antitrust, including the Empagran opinion, reverse payments in the pharmaceutical industry, Congress’s action on ACPERA, Iqbal’s expansion of Twombly’s reach, and the ongoing challenges to class certification.
Have the Courts Gone Too Far Expanding Empagran?
James Robert Noblin, Partner, Blecher & Collins
James Robertson Martin, Partner, Dickstein Shapiro LLP
Kenneth Adams, Partner, Adams Holcomb LLP
Jonathan Cuneo, Partner, Cuneo Gilbert & LaDuca
James J. Fredricks, Appellate Section, Antitrust Division, U.S. Department of Justice
The Legality of Reverse Payments
K. Craig Wildfang, Partner, Robins Kaplan Miller & Ciresi LLP
Joshua P. Davis, Professor and Director, Center for Law and Ethics, University of San Francisco School of Law
Seth Bloom, General Counsel, Subcommittee on Antitrust, Senate Judiciary Committee
Michael Carrier, Professor, Rutgers School of Law-Camden
Renae Steiner, Heins, Mills, and Olson
Hon. Hank Johnson, Chair, Subcommittee on Courts and Competition Policy, Committee on Judiciary, U.S. House of Representatives
Eric B. Fastiff, Lieff, Cabraser, Heimann & Bernstein, LLP
Jay Himes, Partner, Labaton Sucharow LLP
Scott Hammond, Deputy Assistant Attorney General, U.S. Department of Justice
Class Certification in U.S. and Abroad
Philip Nelson, Principal, Economists Incorporated
Linda Nussbaum, Partner, Kaplan Fox & Kilsheimer
Robert Bonsignore, Bonsignore and Brewer
J. Douglas Richards, Partner, Cohen Milstein Sellers & Toll PLLC
George Sampson, Partner, Hagens Berman Sobol Shapiro
Daniel A. Small, Partner, Cohen Milstein Sellers & Toll PLLC
Jonathan Rubin, Partner, Patton Boggs LLP
Eric L. Cramer, Shareholder, Berger & Montague, P.C.
Bert Foer, President, American Antitrust Institute